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Abstract: Two new eudesmane-type sesquiterpenoid lactones, named chlorelactone A (1) and chlorelactone B (2), and one new 
labdane-type diterpenoid, named elatiorlabdane (3), along with seven known sesquiterpenoids and one known disesquiterpenoid 
were isolated from the whole plants of Chloranthus elatior. Their structures and relative configurations were established on the 
basis of extensive spectroscopic analysis. 
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Introduction 
The genus Chloranthus (Chloranthaceae) has about 17 
species in the world, and 13 species and 5 varieties of this 
genus are distributed in China.1,2 Some plants of this genus 
have been used in Chinese folk medicine for the treatment of 
bone fractures.3 Previous work on this genus indicated that 
sesquiterpenoids and disesquiterpenoids were their major 
secondary metabolites.4–11 Disesquiterpenoids were reported to 
exhibit inhibition of cell adhesion molecule expression, 
antifungal activity, anti-HIV-1 activity, tumor growth 
inhibitory activity, potent and selective inhibition on the 
delayed rectifier (Ik）K+ current.10,11 The tyrosinase inhibitory 
activity and cytotoxicity of sesquiterpenoids also have been 
reported.12,13 
Chloranthus elatior is a perennial plant and grows in the 
Southwest of China. Recent phytochemical investigation on 
this species reported 18 compounds including nine  
sesquiterpenoids and four diterpenoids.8 In the course of our 
group searching for new sesquiterpenoids from Chloranthus 
species, two new eudesmane-type sesquiterpenoid lactones, 
named chlorelactone A (1) and chlorelactone B (2), and one 
new labdane-type diterpenoid, named elatiorlabdane (3), along 
with seven known sesquiterpenoids, spathulenol (4),14 4α-
hydroxy-5α,8β(H)-eudesm-7(11)-en-8,12-olide (5),6 4α-
hydroxy-5α,8α(H)-eudesm-7(11)-en-8,12-olide (6),6 neo-
litacumone B (7),15 chlorantholide D (8),8 4α,8β-dihydroxy-
5α(H)-eudesm-7(11)-en-8,12-olide (9),6 chloranthalic acid 
(10),16 and one disesquiterpenoid, chloramultilide C (11)17 
were isolated from the whole plants of C. elatior. Herein, we 
report the isolation and structural elucidation of these compounds. 
 
Results and Discussion 
Chlorelactone A (1) was obtained as a white amorphous 
powder, and its molecular formula was established as 
C15H22O3 by the postive HRESIMS at m/z 273.1463 [M + Na]+ 
(calcd. 273.1466). The 1H NMR spectrum (Table 1) showed 
the presence of two tertiary methyl singlets at H 1.00 and 1.82, 
a secondary methyl at H 0.93 (d, J = 6.0 Hz), and two  
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oxymethine protons at H 3.26 (dd, J = 11.4, 4.1 Hz) and 4.81 
(dd, J = 11.0, 6.4 Hz). The 13C NMR spectrum (Table 1)  
displayed 15 carbon signals, including an α,β-unsaturated ester 
carbonyl at δC 175.2 (s) and two olefinic carbons at δC 120.1 (s) 
and 162.4 (s). The above NMR spectroscopic data suggested 
that 1 was an eudesmane-type sesquiterpenoid lactone, which 
has been widely discovered from this genus.4–8 Comparison of 
NMR data of 1 with those of neolitacumone B (7)15 indicated 
that 1 differed from 7 by the presence of a methyl (δH 0.93, d, 
J = 6.0 Hz and δC 19.8) and a methine (δH 1.48, m and δC 31.6) 
instead of one terminal double bond in 7, which was reasonable
to assume that 1 is the 4,15-dihydrogenation derivative of 7. In 
the HMBC spectrum (Figure 1), the correlations of Me-15 (δH 
0.93) with C-3 (δC 33.8), C-4 (δC 31.6), and C-5 (δC 50.6) were 
observed, which confirmed the above assumption. In addition, 
the HMBC correlations from δH 1.00 (Me-14) to δC 78.2 (C-1), δC 50.6 (C-5), δC 44.5 (C-9), and δC 40.3 (C-10) hinted that 
one hydroxyl group was attached at C-1. The relative  
configuration of 1 was established by a ROESY experiment 
(Figure 2), in which the correlations from Me-14 to H-4 and 
H-8 indicated that they were on the same side of the rings and 
were randomly assigned being β-oriented. Consequently, the 
ROESY correlations of Me-15/H-5 and H-5/H-1 suggested 
that H-1 and H-5 had α-orientation. Thus, compound 1 was 
identified as 1β-hydroxy-4β,5α,8β(H)-eudesm-7(11)-en-12,8α-
olide. 
Chlorelactone B (2) had a molecular formula of C15H18O4 
based on the HREIMS at m/z 262.1211 [M]+ (calcd. 262.1205). 
The NMR data of 2 (Table 1) were very similar to those of 
chlorantholide B8 except for the presence of one more oxyme-
thine (δH 3.84, br. s and δC 75.0) and the absence of a meth-
ylene. The oxymethine was assigned at C-9 according to the 
1H-1H COSY correlations of δH 5.18 (H-8) with δH 3.84 (H-9) 
and HMBC correlations (Figure 1) from H 1.08 (Me-14) to δC 
49.5 (C-1), δC 41.9 (C-5), δC 75.0 (C-9), and δC 44.7 (C-10). 
The ROESY (Figure 2) correlations from δH 1.08 (Me-14) to δH 5.18 (H-8) and 3.84 (H-9) indicated that H-8 and H-9 were 
cofacial and were arbitrarily assigned with a β-orientation. 
Accordingly, the structure of 2 was elucidated as 9α-hydroxy-
5α,8β(H)-2-oxoeudesma-3,7(11)-dien-12,8α-olide. 
Elatiorlabdane (3), white amorphous powder, was assigned 
as C20H30O4 by its exact mass at m/z 334.2144 in HREIMS. 
The IR spectrum showed hydroxyl (3442 cm–1) and two  
carbonyl (1694 and 1680 cm–1) absorptions. The UV  
absorptions at 228 nm indicated the presence of an α,β-
unsaturated ketone. The 1H NMR spectrum (Table 2) showed 
three methyl proton signals at δH 0.80, 1.14, and 1.72, three 
olefinic proton resonances at δH 4.32 (1H, s, H-17), 4.68 (1H, s, 
H-17), and 6.79 (t, J = 5.1 Hz, H-14), and two oxymethylene 
proton signals at δH 4.34 (d, J = 5.1 Hz, H-15). In its 13C NMR 
spectrum, 20 resonances (Table 2) were classified by DEPT 
experiments into three methyls at δC 11.7, 15.4, and 17.1,  
seven methylenes (one oxygenated), two methines, two  
quaternary carbons, four olefinic carbons at δC 150.2 (s), 142.1 
(d), 137.9 (s), and 107.4 (t), a carboxyl at δC 182.4, and a keto 
carbonyl at δC 203.1. The above NMR spectroscopic data and 
the degrees of unsaturation suggested that compound 3 should 
be a bicyclic-labdane diterpenoid.6,18,19 Comprehensive analysis
of 2D-NMR spectrum (HMQC, 1H-1H COSY, and HMBC 
spectrum) of 3 allowed to identify that compound 3 had the 
same planar structure as henrilabdane C [15-hydroxy-12-
oxolabda-8(17),13E-dien-19-oic acid].18,19 Comparison of 
NMR data of 3 with those of henrilabdane C exhibited the 
major difference was the configuration at C-4 as judged from 
the obvious changes of chemical shifts of the carbons around 
C-4. The ROESY cross-peak (Figure 2) from δH 1.14 (Me-19) 




δH (J in Hz) δC δH (J in Hz) δC 
1α 3.26 (dd, 11.4, 4.1) 78.2 (d) 2.88 (d, 16.4) 49.5 (t) 
1β   2.09 (d, 16.4)  
2α 1.62 (m) 30.1 (t)  201.9 (s) 
2β 1.74 (m)    
3α 1.75 (m) 33.8 (t) 5.89 (s) 126.8 (d) 
3β 1.06 (m)   
4 1.48 (m) 31.6 (d)  164.7 (s) 
5 0.86 (m) 50.6 (d) 2.96 (dd, 13.0, 0.9) 41.9 (d) 
6α 2.85 (dd, 14.1, 4.0) 26.3 (t) 3.16 (dd, 13.7, 13.0) 25.6 (t) 
6β 2.02 (dd, 14.1, 13.2)  2.44 (dd, 13.7, 0.9)  
7  162.4 (s)  160.0 (s) 
8 4.81 (dd, 11.0, 6.4) 78.4 (d) 5.18 (br. s) 81.1 (d) 
9α 0.93 (dd, 12.3, 11.0) 44.5 (t) 3.84 (br. s) 75.0 (d) 
9β 2.76 (dd, 12.3, 6.4)    
10  40.3 (s)   44.7 (s) 
11  120.1 (s) 123.7 (s) 
12  175.2 (s)  177.6 (s) 
13 1.82 (s) 8.5 (q) 1.86 (s) 8.2 (q) 
14 1.00 (s) 11.4 (q) 1.08 (s) 16.2 (q) 
15 0.93 (d, 6.0)  19.8 (q)  2.07 (s) 22.2 (q) 















Figure 1.  1H-1H COSY ( ) and key HMBC (→) correlations 
of 1–3 
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to δH 0.80 (Me-20) suggested that Me-19 was β-oriented. In 
addition, the correlations of H2-15 with Me-16 in the ROESY 
spectrum suggested a 13E-configuration. Therefore, the  




General Experimental Procedures. Optical rotations were 
measured on a JASCO P-1020 digital polarimeter. UV spectra 
were measured using a Shimadzu UV-2401 PC spectrapho-
tometer. IR spectra were obtained on a Bruker Tensor-27  
infrared spectrophotometer with KBr pellets. ESIMS spectra 
were recorded on a Bruker HTC/Esquire spectrometer, 
HRESIMS spectrum was recorded on an API Qstar Pulsar  
instrument. HREIMS spectra were recorded on a Waters 
AutoSpec Premier P776 instrument. 1D and 2D NMR experi-
ments were performed on Bruker AM-400 and Avance III 600 
instruments with TMS as the internal standard. Chemical shifts 
(δ) were expressed in ppm with reference to the solvent signals. 
Column Chromatography (CC) was performed on silica gel 
(200–300 mesh, Qingdao Marine Chemical Ltd., Qingdao, 
China), MCI-gel CHP20P (75–150 μm; Mitsubishi Chemical 
Co.), and Sephadex LH-20 (GE Healthcare). Semi-preparative 
HPLC was run on Agilent 1100 liquid chromatograph with 
diode array detector (DAD), Zorbax-SB-C18 column (5 μm; 
25 cm × 9.4 mm i.d.). Fractions were monitored by TLC 
(GF254, Qingdao Marine Chemical Ltd., Qingdao, China), 
and spots were detected with a UV254 lamp and by heating 
silica gel plates sprayed with 10% H2SO4 in ethanol. 
 
Plant Materal. Whole plants of C. elatior were collected in 
November 2009 from Jinghong, Yunnan Province, China, and 
identified by Mr. Yu Chen of Kunming Institute of Botany, 
CAS. A voucher specimen (No. HY0010) has been deposited 
in the State Key Laboratory of Phytochemistry and Plant  
Resources in West China, Kunming Institute of Botany,  
Chinese Academy of Sciences. 
 
Extraction and Isolation. The dried whole plants (5.4 kg) 
were powered and extracted with 95% EtOH under reflux (3 × 
20 L) and filtrated. The filtrate was concentrated and  
partitioned between EtOAc (3 × 2.0 L) and H2O. The EtOAc 
fraction (201 g) was chromatographed on silica gel column 
eluting with petroleum ether-acetone (200:1→5:1) to afford 
fractions I–VI. Fraction I and II were mainly fatty acids and 
sterols. Fraction III (12 g) was further isolated and purified by 
silica gel (petroleum ether-EtOAc, 150:1) to yield 4 (11 mg). 
Fraction IV (62 g) was subjected to an MCI gel column  
chromatography (MeOH-H2O, 1:1→1:0, v/v) to get subfrac-
tions IVa and IVb. Fr. IVa was separated by silica gel CC  
(petroleum ether-EtOAc, 10:1) to get 5 (7 mg), while Fr. IVb 
was separated  by silica gel  CC (petroleum ether-EtOAc, 10:1) 
and then semi-preparative HPLC to obtain 1 (2 mg), 6 (3 mg), 
7 (10 mg), and 8 (11 mg). Fraction V (31g) was dealt with a 
MCI gel and a silica gel CC (CHCl3-MeOH, 200:1) to afford 
11 (15 mg). Fraction VI (45 g) was subjected to a MCI gel CC 
to get three subfractions (VIa, VIb, and VIc), which were  
extensively purified on a silica gel column (CHCl3-MeOH, 
100:1) and Sephadex LH-20 (MeOH) to afford 9 (15 mg) and 
10 (8 mg) from Fr. VIa, afford 3 (11 mg) from Fr. VIb, and 
afford 2 (9 mg) from Fr. VIc. 
 
Chlorelactone A (1): white amorphous powder; [α] 13D   + 
21.3 (c 0.20, MeOH); UV (MeOH) λmax (log ε) 238 (2.16) nm; 
IR (KBr) νmax 3447, 2954, 2926, 2869, 2853, 1746, 1680, 1462, 
1444, 1110, 1075, 1035, 1019 cm–1; 1H and 13C NMR data see 
Table 1; ESIMS m/z 273 [M + Na]+; HRESIMS, m/z 273.1463 
([M + Na]+, calcd. for C15H22O3Na, 273.1466). 
 
Chlorelactone B (2): white amorphous powder; [α] 26D   + 
48.8 (c 0.15, MeOH); UV (MeOH) λmax (log ε) 225 (2.22) nm; 
IR (KBr) νmax 3433, 2926, 2858, 1751, 1660, 1437, 1382, 1333, 
Table 2. 1H and 13C NMR spectroscopic data of compound 3 (400 MHz; CD3OD; δ in ppm) 
pos. δH (J in Hz) δC pos. δH (J in Hz) δC 
1α 1.17 (m) 39.5 (t) 11a 3.05 (dd, 16.8, 10.0) 33.8 (t) 
1β 1.68 (m)  11b 2.64 (dd, 16.8, 3.2)  
2α 1.59 (m) 19.5 (t) 12 203.1 (s) 
2β 1.63 (m)  13 137.9 (s) 
3α 1.80 (m) 38.3 (t) 14 6.79 (t, 5.1) 142.1 (d) 
3β 2.12 (m)  15 4.34 (d, 5.1) 60.1 (t) 
4  39.3 (s)    
5 2.08 (dd, 12.5, 2.8) 50.9 (d) 16 1.72 (s) 11.7 (q) 
6α 1.36 (m) 27.4 (t) 17 4.68 (s) 107.4 (t) 
6β 1.46 (m)   4.32 (s)  
7α 2.32 (m) 38.2 (t) 18 182.4 (s) 
7β 1.59 (m)  19 1.14 (s) 17.1 (q) 
8  150.2 (s) 20 0.80 (s) 15.4 (q) 
9 2.56 (d, 9.4) 53.4 (d)  






































































Figure 2.  Key ROESY correlations of compounds 1–3 
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1292, 1265, 1120, 1104, 1069, 1050 cm–1; 1H and 13C NMR 
data see Table 1; ESIMS m/z 285 [M + Na]+; HREIMS, m/z 
262.1211 ([M]+, calcd. for C15H18O4, 262.1205). 
 
Elatiorlabdane (3): white amorphous powder; [α]26D   – 18.6 
(c 0.26, MeOH); UV (MeOH) λmax (log ε) 228 (2.88) nm; IR 
(KBr) νmax 3442, 2930, 2868, 1694, 1680, 1643, 1461, 1451, 
1387, 1275, 1021 cm–1; 1H and 13C NMR data see Table 2; 
ESIMS m/z 333 [M – H]–; HREIMS, m/z 334.2144 ([M]+, 
calcd. for C20H30O4, 334.2144). 
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